Summary
Animal models for Epstein-Barr virus (EBV) are restricted to some species of new-world monkeys which develop malignant lymphoid tumours or benign lymphoproliferative diseases after virus inoculation. Similar pathological features were induced in rabbits by the EBV-related herpesvirus ofMacaca arctoides (HVMA). In this study 17 of 32 rabbits infected with varying amounts of HVMA produced from MAL-1 cells developed lymphoproliferative disorders. In 13 rabbits high-grade malignant lymphomas were detected, 4 rabbits revealed the histopathological feature of lymphoid hyperplasia. These lympho-proliferations were shown to be associated with HVMA by PCR and by the expression of EBV-like RNAs (EBER) in 14 and 10 cases, respectively. The homology in the polymerase gene region between DNA from EBV and HVMA, and from HVMA and the malignant tissue was found to be 94.8% and 100%, respectively. All the infected animals produced antibodies to antigens corresponding to early and late EBV proteins. By studying the HVMA expression in MAL-1 cells EBV-like proteins expressed in latency (EBNA1 and EBNA2) and in the lytic cycle (VCA, EA) were detected. Our findings suggested that HVMA caused a symptomatic infection in rabbits with pathological features that fit the conditions of an animal model suitable for testing antiviral drugs and vaccines against EBV.
Similar content being viewed by others
References
Arrand JR, Rymo L (1982) Characterization of the major Epstein-Barr virus specific RNA in Burkitt lymphoma-derived cells. J Virol 41: 376–389
Baer RJ, Bankier AT, Biggin MD, Deininger PL, Farrel PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Seguin C, Tuffnell PS, Barrell BG (1984) DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310: 207–211
Baskin GB, Martin LN, Ragan SRS, Gormus BJ, Corb MM, Wolf RH, Soike KF (1986) Transmissible lymphoma and SAIDS in rhesus monkeys. J Natl Cancer Inst 77: 105–122
Cordell JL, Falini B, Erber WN, Ghosh AK, Abdhulaziz Z, MacDonald S, Pulford KAF, Stein H, Mason DY (1984) Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal antialkaline phosphatase (APAAP complexes). J Histochem Cytochem 32: 219–229
Deinhardt F, Deinhardt J (1979) Comparative aspects: oncogenic animal herpesviruses. In: Epstein MA, Achong BG (ed) The Epstein-Barr virus. Springer, Berlin Heidelberg New York, pp 374–400
Dillner J, Rabin H, Letvin N, Henle W, Henle G, Klein G (1987) Nuclear DNA-binding proteins determined by the Epstein-Barr virus-related simian lymphotropic herpesvirusesH. gorilla, H. pan, H. pongo andH. papio. J Gen Virol 68: 1587–1596
Falk L, Deinhardt F, Nonoyama M, Wolfe LG, Bergholz C (1976) Properties of a baboon lymphotropic herpesvirus related to Epstein-Barr virus. Int J Cancer 18: 798–807
Falk L, Deinhardt F, Wolfe L, Johnson D, Hilgers J, De-Thé G (1976) Epstein-Barr virus: experimental infection ofCallithrix jacchus marmosets. Int J Cancer 17: 785–788
Feichtinger H, Li S-L, Kaaya E, Putkonen P, Grünewald K, Weyrer K, Böttiger D, Ernberg I, Linde A, Biberfeld G, Biberfeld P (1992) A monkey model for Epstein Barr virus-associated lymphomagenesis in human acquired immunodeficiency syndrome. J Exp Med 176: 281–286
Grässer FA, Murray PG, Kremmer E, Klein E, Remberger K, Feiden W, Reynolds G, Niedobitek G, Young LS, Mueller-Lantzsch N (1994) Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1: immunhistological detection of EBNA 1 in the malignant cells of Hodgkin's disease. Blood 84: 3792–3798
van Grunsven WMJ, van Heerde EC, de Haard HJW, Spaan WJM, Middeldorp JM (1993) Gene mapping and expression of two immunodominant Epstein-Barr virus capsid proteins. J Virol 67: 3908–3916
Hammerschmidt W, Sugden B (1989) Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 340: 393–397
Henle H, Henle G (1985) Epstein-Barr virus and human malignancies. Adv Viral Oncol 5: 201–238
Henle W, Henle G, Andersson J, Ernberg I, Klein G, Horwitz CA, Marklund G, Rymo L, Wellinder C, Straus SE (1987) Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection. Proc Natl Acad Sci USA 84: 570–574
Kiene P, Milde-Langosch K, Runkel M, Schulz K, Löning T (1992) A simple and rapid technique to process formalin-fixed, paraffin-embedded tissues for the detection of viruses by the polymerase chain reaction. Virchows Arch A Pathol Anat Histopathol 420: 269–273
Lapin B (1988) Baboon lymphoma viruses. In: Darai G (ed) Virus diseases in labortatory and captive animals. Nijhoff, Boston, pp 135–151
Lapin BA, Timanovskaya VV, Yakovleva LA (1985) Herpesvirus HVMA: a new representative in the group of the EBV-like B-lymphotrophic herspesviruses of primates. In: Neth R, Gallo RC, Greves MF, Janka G (eds) Modern trend in human leukemia VI. Springer, Berlin Heidelberg New York, pp 312–313 (Hematology and Blood Transfusion, vol 29)
Lennert K, Feller AC (1990) Histopathologie der Non-Hodgkin-Lymphome (nach der aktualisierten Kiel-Klassifikation). Springer, Berlin Heidelberg New York Tokyo
Lerner, MR, Andrews NC, Miller G, Steitz JA (1981) Two small RNAs encoded by Epstein-Barr viral DNA and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 78: 805–809
Miller G (1979) Experimental carcinogenicity by the virus in vivo. In: Epstein MA, Achong BG (eds) The Epstein-Barr virus. Springer, Berlin Heidelberg New York, pp 351–372
Modrow S, Wolf H (1986) Characterization of two related Epstein-Barr virus encoded membrane proteins that are differentially expresses in Burkitt lymphoma and in vitro transformed cell lines. Proc Natl Acad Sci USA 83: 5703–5707
Mosier DE, Gulizia RJ, Baird SM, Spector S, Spector D, Kipps TJ, Fox RI, Carson DA, Cooper N, Richman DD, Wilson DB (1989) Studies of HIV infection and the development of Epstein-Barr virus-related B cell lymphomas following transfer of human lymphocytes to mice with severe combined immunodeficiency. Curr Top Microbiol Immunol 152: 195–199
Ohno S, Luka J, Falk L, Klein G (1977) Detection of a nuclear, EBNA-type antigen in apparently EBNA-negativeHerpesvirus papio (HVP)-transformed lymphoid lines by the acid-fixed nuclear binding technique. Int J Cancer 20: 941–946
Rabin H, Neubauer RH, Hopkins RF, Dzhikidze EK, Shevtsova ZV, Lapin BA (1977) Transforming activity and antigenicity of an Epstein-Barr-like virus from lymphoblastoid cell line of baboons with lymphoid disease. Intervirology 8: 240–249
Rawlins DR, Milman G, Hayward SD, Hayward GS (1985) Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites of the plasmid maintenance region. Cell 42: 859–868
Rowe M, Rowe DT, Gregory CD, Young LS, Farrell PJ, Rupani H, Rickinson AB (1987) Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J 6: 2743–2751
Sambrook J, Fritsch EF, Maniatis T (1989) Isolation of DNA from mammalian cells: protocol I. In: Molecular cloning. A laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Laboratory Press, New York, pp 9.16–9.19
Schätzl H, Yakovleva L, Lapin B, Rose D, Inzhiia L, Gaedigk-Nitschko K, Deinhardt F, von der Helm K (1992) Detection and characterization of T-cell leukemia virus-like proviral sequences in PBL and tissues of baboons by PCR. Leukemia 6 [Suppl 3]: 158–160
Schätzl H, Tschikobava M, Rose D, Voevodin A, Nitschko H, Sieger E, Busch U, von der Helm K, Lapin B (1993) The Sukhumi primate monkey model for viral lymphogenesis: high incidence of lymphomas with presence of STLV-I and EBV-like virus. Leukemia 7 [Suppl 2]: 86–92
Watanabe T, Seiki M, Hirayama Y, Yoshida M (1986) Human T-cell leukemia virus type-I is a member of the African subtype of simian viruses (STLV). Virology 148: 385–388
Wolf H, Motz M, Kühbeck R, Jilg W, Fan J, Pi GH, Zeng Y (1987) Development of a set of EBV-specific antigens with recombinant gene technology for diagnosis of EBV-related malignant or non-malignant diseases. In: Levine PH, Ablashi DV, Nonoyama M, Pearson GR, Glaser R (eds) Epstein-Barr virus and human diseases. Humane Press, Clifton, pp 179–182
Wolf H, Bogedain C, Schwarzmann F (1993) Epstein-Barr virus and its interaction with the host. Intervirology 35: 26–39
Yakovleva LA, Timanovskaya VV, Voevodin AF, Indzhiia LV, Lapin BA, Ivanov MT, Markaryan DS (1987) Modelling of malignant lymphoma in rabbits using oncogenic viruses of non-human primates. In: Neth R, Gallo RC, Greaves MF, Kabisch H (eds) Modern trends in leukemia VII. Springer, Berlin Heidelberg, New York Tokyo, pp 445–447 (Hematology and Blood Transfusion, vol 32)
Yates JL, Warren N, Sugden B (1985) Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313: 812–815
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wutzler, P., Meerbach, A., Färber, I. et al. Malignant lymphomas induced by an Epstein-Barr virus-related herpesvirus fromMacaca arctoides — a rabbit model. Archives of Virology 140, 1979–1995 (1995). https://doi.org/10.1007/BF01322687
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01322687